Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Clinical trial NCT00983853 · COMPLETED
Trial details
- NCT number
- NCT00983853
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2012-03-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.